Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Wu Xiaobin, President, COO, and GM China at BeiGene , Ltd. (NASDAQ:BGNE), executed a series of transactions involving the company’s American Depositary Shares (ADS) on April 1, 2025. The most notable activity was the sale of 51,921 ADS, bringing in a total of approximately $14.6 million. These shares were sold at prices ranging from $280.31 to $283.79 per share. The transaction occurred as BeiGene trades near its 52-week high, with InvestingPro analysis indicating the stock is currently overvalued.
In addition to the sales, Wu also exercised options to acquire 51,921 ADS at prices between $119.96 and $174.43, totaling $8.16 million in value. Following these transactions, Wu’s direct ownership stands at 17,304 ADS, with an additional 4,000 ADS indirectly owned by his wife. The company shows strong growth potential with a 67% revenue CAGR over five years, though its Altman Z-Score of 0.9 suggests some financial stability concerns. For deeper insights into BeiGene’s valuation and growth prospects, including exclusive ProTips and comprehensive analysis, check out the full research report on InvestingPro.
In other recent news, BeiGene Ltd (NASDAQ:ONC) reported a 55% increase in total revenue for 2024, reaching $3.8 billion, with a notable 77% growth in product revenue for the fourth quarter. The company also introduced 13 new molecular entities to the clinic and completed an $800 million manufacturing facility. Looking ahead, BeiGene projects 2025 revenue between $4.9 billion and $5.3 billion. The company aims to achieve GAAP operating breakeven in 2025, with multiple Phase III trials planned for chronic lymphocytic leukemia and mantle cell lymphoma. In terms of analyst activity, the company received inquiries about its strategy for developing BTK degraders and potential fixed-duration treatments. BeiGene’s leadership emphasized the company’s strategic vision and commitment to innovation, highlighting its ongoing expansion in key markets, particularly in the U.S., which accounted for 55% of Q4 revenues. The company’s cash position stood at $2.6 billion as of year-end 2024, supporting its growth and innovation initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.